Dysbiosis of the gut mucosa-associated microbiota (MAM) plays a pivotal role in the pathogenesis of chronic inflammatory bowel diseases (IBD). To date, dysbiosis only describes the altered composition of the different bacterial populations, but little is known about transcriptional activity, metabolism and the 'live' status of the MAM. In this study we investigated the transcriptional activity of the dominant intestinal bacterial populations in patients with IBD. Colonic mucosal biopsies from patients with active Crohn's disease (CD; n510), active ulcerative colitis (UC; n510) and healthy individuals (HI; n510) were compared by 16S rRNA gene and rRNA profiles using clone libraries with more than 1700 sequenced clones. Bacterial richness was significantly lower in clone libraries based on rRNA compared to those based on the rRNA genes in the CD group (3.01 vs 3.91) and the UC group (3.61 vs 4.15), but showed no difference in HI (3.81 vs 3.85). The qualitative composition of rRNA and rRNA gene clone libraries was significantly different, with the phylum Bacteroidetes being the most active (P,0.01) compared to other populations in all clinical groups. In contrast, Actinobacteria and Firmicutes were inactive in the CD group, while Escherichia sp. were both abundant and active in the CD and UC groups. Most of the phylotypes showing the highest activity index ratios represented less than 1 % of the microbiota. Our findings indicate that specific bacterial populations are activated in IBD patients, while other groups are in an inactive or 'dormant' state. The transcriptional activity points to a more functional role of the intestinal mucosal microbiota and may lead to the identification of therapeutic targets in the active modulation of microbial factors.
INTRODUCTION
Chronic inflammatory bowel diseases (IBD) are characterized by dysbiosis of the intestinal microbiota (Ott et al., 2004; Tamboli et al., 2004; Manichanh et al., 2006) . Dysbiosis is discussed as a major factor in disease pathogenesis along with genetic mutations and a dysregulation of the immune response to bacterial antigens (Schreiber et al., 2005) . Loss of natural intestinal diversity and a shift of bacterial composition towards a more deleterious profile might reflect the net effect of environmental influences over the past few decades leading to the dramatic increase of the incidence of IBD in the industrialized world (Ott et al., 2004 (Ott et al., , 2008a Manichanh et al., 2006) . To date, dysbiosis only describes the altered composition of the different bacterial populations, but little is known about transcriptional activity, metabolism and 'live' status of the mucosa-associated microbiota (MAM), which may have more relevance for the host, e.g. by direct contact with the gut epithelium, secretion of pro-inflammatory cytokines, quorum-sensing molecules or other microbe-associated molecular patterns.
A maximum of 10-30 % of the total microbes of the complex bacterial ecosystem within the gut can be cultivated using classical microbiological approaches (McFarlene & Gibson, 1994; Langendijk et al., 1995; Wilson & Blitchington, 1996; Hugenholtz et al., 1998; Suau et al., 1999; Tannock, 2001 Tannock, , 2002 . New cultivationindependent techniques based on ribosomal marker genes (rRNA genes/rRNA) have facilitated the understanding of the composition of microbial communities (McFarlene & Gibson, 1994; Langendijk et al., 1995; Wilson & Blitchington, 1996; Hugenholtz et al., 1998; Tannock, 2001 Tannock, , 2002 . Analysis of the 16S rRNA gene has previously been targeted to describe bacterial variability of the intestinal MAM in IBD patients and healthy individuals (HI) (Poxton et al., 1997; Zoetendal et al., 2002; Lepage et al., 2005; Seksik et al., 2005; Gophna et al., 2006) . The taxonomic and phylogenetic information obtained by the 16S rRNA gene approach reflects the global composition of a microbial community, but contains no further characterization on the transcriptional status and 'activity' of the intestinal microbiota. The transcriptional status of bacteria is represented by expression of mRNA equivalents, thus detection of bacterial rRNA correlates with metabolic activity. Two works identified active faecal bacteria in HI and patients with IBD (Zoetendal et al., 1998; Sokol et al., 2006) using rRNA-based fingerprinting approaches, yet faecal microbiota differs from the MAM Eckburg et al., 2005) .
In the present study diversity and transcriptional activity of the intestinal MAM was investigated in patients with Crohn's disease (CD), ulcerative colitis (UC) and HI by comparison of their rRNA and rRNA gene sequences in order to dissect the metabolic status from the mere presence of intestinal microbiota and to gain more functional information about active components of the MAM in IBD patients.
METHODS
Patients. Ten patients with CD, ten patients with UC and ten HI were included in this study. All participants were of white ethnicity. The diagnosis of IBD was made in accordance with established clinical, endoscopic, histological and radiological criteria (Ott et al., 2004) . Disease activity was assessed by the CD activity index (CDAI) for CD patients and the clinical activity index (CAI) for UC patients. All IBD patients were in an active phase of the disease (CDAI .150 in the CD group and CAI .4 in the UC group). The demographic data for the patients enrolled are shown in Table 1 . Biopsies were sampled from macroscopic sites of inflammation in the sigmoid colon. To assess inflammatory activity, histological parameters were determined for IBD patients by a pathologist following the criteria described by Geboes & Dalle (2002) and Geboes et al. (2000) . The control group included HI (from screening colonoscopies without pathological macroscopic or histological findings). Inclusion criteria were that no antibiotic therapy had been administered at the time of investigation and in the last 6 months. Patient interviews about their nutritional habits revealed neither a significant difference in the uptake of food containing fungal components (e.g. cheese) nor a significant difference in the use of parenteral or formula diets.
DNA and RNA extraction. DNA and RNA were extracted simultaneously from individual biopsies using the AllPrep DNA/ RNA mini kit (Qiagen) according to the manufacturer's instructions. The concentration and purity of DNA and RNA was assessed photometrically. To check for DNA contamination in the RNA preparations, PCR was performed using the primers GADPH_F2 and GADPH_R2 amplifying 334 bases from the glyceraldehyde-3phosphate dehydrogenase-encoding gene.
Reverse transcription of RNA. Reverse transcription was performed using MMLV reverse transcriptase (Promega). A mixture of 0.5 mg total RNA, 1 ml random primers (Promega) and 1 ml RNase inhibitor (Promega) was incubated for 5 min in a total volume of 10 ml at 70 uC and cooled on ice. After adding 4 ml MMLV 56reaction buffer (Promega), 20 mM dNTPs and, finally, 1 ml MMLV reverse transcriptase in a total volume of 20 ml, the reaction mixture was incubated for 2 h at 42 uC.
PCR amplification of 16S rRNA and rRNA genes. A selected region of the 16S rRNA gene, including the variable regions V4 and V5 (Escherichia coli reference positions 519-926), was amplified separately from each individual with the universal bacterial primers Com1 and Com2 as previously described (Ott et al., 2004) . PCR products were analysed by 1.5 % agarose gel electrophoresis to ascertain amplicon size (about 400 bp).
Cloning and sequencing. Amplicons were purified with a MinElute PCR purification kit (Qiagen). The same amount of rRNA gene and rRNA PCR products from the same clinical group were pooled and cloned into competent Escherichia coli cells using the PCR 2.1 TOPO TA cloning kit (Invitrogen). Six clone libraries were constructed (both rRNA and rRNA gene for each clinical group) containing 288 clones each. Inserts were amplified using the vector specific primers M13F and M24R as described previously (Ott et al., 2004) . Sequencing of inserts was performed with an ABI Prism 3700 DNA analyser in a final volume of 10 ml using 1 ml ABI Prism BigDye (Applied Biosystems) at a concentration of 3.2 mM vector-specific primers according to the following protocol: 96 uC for 1 min; 25 cycles of 96 uC for 10 s, 53 uC for 5 s and 60 uC for 4 min.
Sequence analysis and phylotype determination. The resultant sequences were checked for possible chimeric artefacts by the chimera check program (Ribosomal Database Project II, RDP II-http://rdp. cme.msu.edu) (Cole et al., 2003) . For phylogenetic affiliation, sequences from rRNA and rRNA gene libraries were subjected to National Center for Biotechnology Information BLAST analysis (http:// www.ncbi.nlm.nih.gov/BLAST) and the sequences match and classifier program at RDP II (http://rdp.cme.msu.edu/) (Cole et al., 2007 (Cole et al., , 2009 . Sequences were aligned using the CLUSTAL_X program and alignment was refined with BioEdit software (version 7.0.5.3). Distance matrices for each library were calculated with the DNADIST (Schloss & Handelsman, 2004) phylotype or OTU (operational taxonomic unit) using the DOTUR software (distance-based OTU and richness) (Schloss & Handelsman, 2005) . Additionally, the ARB database (http://www.arb-home.de) was used for ribosomal sequences and sequence handling; the VecScreen database (http://www.ncbi.nlm.nih.gov/VecScreen/VecScreen.html) was also used.
Statistical analysis and comparison of 16S clone libraries.
Good's coverage estimation was calculated as [1 -(n/N)]6100, where n is the number of singleton sequences and N is the total number of sequences within the analysed clone library. Estimates of phylotype richness were calculated according to the abundance-based coverage estimator (ACE) (Chao & Lee, 1992) and the bias-corrected Chao1 estimator (Chao, 1984) . Collector's curves of observed and estimated richness were calculated using DOTUR (Schloss & Handelsman, 2005) .
A principal component analysis was performed to document the distances between phylotype composition and quantity among rRNA and rRNA gene libraries, generated from HI, CD patients and UC patients. Phylotype constitution similarities among clinical groups were compared by using the Sorensen index, C s 52 J/(a+b), where J is the number of common shared phylotypes found in both libraries (i.e. A and B) subjected to comparison, a is the total number of phylotypes in library A and b is the total number of phylotypes in library B. To determine if a phylotype is active or dormant, activity index ratios (AIRs) at different taxonomical levels were calculated (AIR5 percentage of sequences in rRNA library/percentage of sequences in rRNA gene library).
Ethical considerations. The protocol was approved by the review board of the Medical Faculty of the Christian Albrechts University (CAU) in Kiel prior to use. All patients gave written informed consent prior to colonoscopy.
RESULTS
A total of 1728 clones were sequenced using vector-specific primers and 1571 were considered for further analysis (after exclusion of chimera, eukaryotic sequences and low quality sequences). Clones with ¢97 % sequence similarity were grouped into phylotypes according to Schloss & Handelsman (2004) . The numbers of clones and phylotypes analysed in the different groups are presented in Table 2 . The Good's coverage estimates ranged from 71.36 % in UC rRNA gene library to 83.26 % in CD rRNA, indicating the good quality of the libraries and sufficient representation of diversity (Table 2) . Among the rRNA gene libraries we observed a reduced number of phylotypes in CD patients (n579) and an increased number in UC patients (n5101) compared to controls (n587). The direct comparison of rRNA gene and rRNA libraries revealed equal numbers of phylotypes among the HI (n587 each), while the number of phylotypes in CD and UC patients was higher in rRNA gene libraries compared to the corresponding rRNA libraries indicating a discrepancy between the diversity of transcriptionally active bacteria (rRNA) and bacteria present (rRNA gene) in IBD patients. Likewise, principal component analysis of phylotypes from the different clone libraries showed that variation along the first two principal axes was influenced by the clinical status and type of nucleic acid used to generate clone libraries.
Libraries from rRNA or rRNA gene seemed to be similar in HI, whereas rRNA and rRNA gene libraries differed in both CD and UC groups (Fig. 1 ). Furthermore, rRNA and rRNA gene libraries from HI shared more common phylotypes (Sorensen similarity index 0.609) compared with CD patients (Sorensen similarity index 0.434) and UC patients (Sorensen similarity index 0.427). A small part of phylotypes had no representation in rRNA gene libraries but was present in rRNA clone library and vice versa. It was noteworthy that bacterial phylotypes activity was not linked to their prevalence in the rRNA gene libraries. Within the three clinical groups, most of the phylotypes showing the highest AIRs represented less than 1 % of the microbiota (Fig. 2) .
Regardless of the clinical status or type of nucleic acid (rRNA or rRNA gene), phylotypes clustered into the four main phyla Firmicutes, Bacteroidetes, Proteobacteria and Actinobacteria. The percentage representations of sequences in each phylum are shown in Table 3 . Phylotypes with significant number of clones and high AIRs in HI' libraries were related to species Catenibacterium mitsuokai, Clostridium innocuum and Clostridium ramnosum, whereas phylotypes related to Clostridium leptum, Dorea longicatena and Eubacterium biforme were less active in HI (Fig. 3) . Ruminococcus gnavus and related phylotypes were found to be active in HI (AIR52.217) and CD patients, while they showed less activity in UC patients (AIR50.27).
In contrast, Ruminococcus lactaris and related phylotypes showed low activity in HI and UC patients, but were active in CD patients. In the CD group, phylotypes with high activity ratios belonged to: Clostridium ramnosum and Eubacterium ramulus. However, phylotypes showing low AIRs in the CD group were related to bacterium mpn-isolate group 18, genus Lachnospiraceae incertae sedis, Faecalibacterium prausnitzii L2-6, Roseburia intestinalis L1-82 and Eubacterium biforme.
Four butyrate-producing bacteria SL6/1/1 related phylotypes were found to be active members of the intestinal community in UC patients. Similarly, Ruminococcus obeum 1-33 related phylotypes were also found to be more active in UC patients compared with HI and CD patients (Fig. 3) . The complete list of phylotypes is available in Supplementary Table S1 (available with the online journal). 
Bacteroides are prevalent and active in CD patients
Bacteroidetes Bacteroides fragilis-related phylotypes were less represented in CD patients compared to HI or UC patients, but AIR of this species was the highest in CD patients (AIR510.46 in CD vs 2.87 in HI and 1.31 in UC). Likewise, phylotypes related to Bacteroides vulgatus constituted active members in CD patients compared to HI or UC patients and was also the overall most active phylotype in the CD group with an AIR of 53.04 (Fig. 3) . Interestingly, three phylotypes, close relatives of Bacteroides eggerthii were present only in the CD rRNA gene library indicating dormant behaviour of this species in the CD group (see Supplementary Table S1 available with the online journal). Bacteroides sp. AR20 and Bacteroides dorei-related phylotypes were specifically observed in libraries generated from UC individuals, with Bacteroides sp. AR20 showing a dormant/inactive status (AIRs below 1) while the latter was active (Fig. 3) . 
Escherichia coli is prevalent and active in UC patients
Phylotypes related to Escherichia coli were detected in all libraries, with a higher prevalence in UC patients (10.57 %) compared to CD patients (7.59 %) and HI (0.37 %). However, Escherichia coli phylotypes were active in all three clinical groups with AIR ranging from 1.68 in the CD group to 3.19 in the HI group (Fig. 3 , Supplementary Table  S1 available with the online journal).
Actinobacteria are less active in CD patients and more active in UC patients
Actinobacteria (high G+C content Gram-positive bacteria) of the genera Bifidobacteria, Eggerthella and Collinsella were detected in all three clinical groups. The overall prevalence of this phylum was increased in CD patients (12.94 % of the total microbiota) in comparison to HI (6.64 %) and UC patients (2.64 %) (Table 3) . Dominant bacteria from this phylum in CD patients were Collinsella aerofaciens and Eggerthella genus. However, the only active bacteria within the Actinobacteria was related to Bifidobacterium bifidum and was only observed in UC patients (AIR54.09).
DISCUSSION
Dysbiosis of the mucosa-associated intestinal microbiota is one of the major characteristics in patients with chronic IBD. Previous microbiological studies have produced conflicting results about the nature of dysbiosis in IBD patients and the contribution to disease pathogenesis and pathophysiology (Ott et al., 2004 (Ott et al., , 2008a Manichanh et al., 2006; Gophna et al., 2006; Lucke et al., 2006; Frank et al., 2007) . Generally, dysbiosis seems to be independent of whether the sample originated from inflamed or noninflamed sites (Vasquez et al., 2007) . New molecular techniques based on the 16S rRNA gene allowed fresh insights into the composition of the complex intestinal microbiota and their alterations in inflammatory gastrointestinal disorders. However, the detection of 16S rRNA gene signatures provides important information about the presence of bacteria, but does not predict the functional status of micro-organisms. The ratio between 16S rRNA and 16S rRNA genes is a predictor of the metabolic status of bacteria in a microbial community, and allows the differentiation between active and inactive members of the intestinal microbiota (Wagner, 1994) . A higher transcriptional activity corresponds to a higher cell replication rate and greater protein production. Therefore, the lack of an exact definition of the dysbiotic status of the IBD microbiota might be attributed to the unidirectional view on micro-organisms by a DNA-based approach.
Fingerprinting techniques and fluorescence in situ hybridization combined with flow cytometry have previously been implicated to detect metabolically active bacteria in faecal samples of HI and patients with IBD (Zoetendal et al., 1998; Sokol et al., 2006; Rigottier-Gois et al., 2003) . In UC patients, Sokol et al. (2006) observed an active Escherichia coli (or related Enterobacteria) significantly associated with faeces from UC patients compared to HI. In faecal samples of 23 HI, significant differences were found for Bacteroides and Atopobium comparing 16S rRNA and 16S rRNA genes (Rigottier-Gois et al., 2003) . In our study, the prevalence of Escherichia coli was highlighted at the mucosal level in IBD patients, mostly in UC patients. If the AIR of Escherichia coli in HI was higher than in IBD patients, the corresponding phylotype accounted for only 0.37 % of the total microbiota in the HI group compared to 9.25 % in the UC group. Thus, Escherichia coli is also an active species of the MAM in UC patients. This bacterial species has already been implicated in IBD dysbiosis (Giaffer et al. 1992; Darfeuille-Michaud et al., 1998) .
The overall diversity on the rRNA gene level revealed a decreased diversity in CD patients compared to controls as reported previously (Ott et al., 2004) . This was mainly due to a lower diversity within the phylum Firmicutes, in line with a previous study based on metagenomic analysis of the faecal microbiota in CD patients (Manichanh et al., 2006) . Interestingly, bacterial phylotype numbers in UC patients were increased compared to the HI group. Previously our group demonstrated a reduced diversity in UC patients (Ott et al., 2004) , also by applying an electrophoretic approach (generally able to distinguish dominant and abundant microbiota), differences between studies might be due to different methodological approaches: in contrast to the electrophoretic approach, the clone library methodology used in the current study could also pick under-represented bacterial strains/species. A baseline analysis of the relative proportions of rRNA and rRNA gene sequences revealed a balanced ratio in the controls, but showed a significant lack of transcriptional activity in IBD patients. If the bacterial diversity of Firmicutes was low only in CD patients, activity of bacteria from this phylum was dramatically decreased in both IBD groups compared to HI. Phylotypes uniquely active in HI were mainly related to the family Lachnospiraceae (63 %) or the family Erysipelotrichaceae (27 %). This might suggest a key role of these bacteria in homeostasis maintenance, or a stronger vulnerability toward inflammatory response.
The prevalence of Bacteroides sp. in IBD patients is in agreement with other studies (Swidsinski et al., 2002; Hartley et al., 1992) . Bacteroides sp. produce mucindegrading sulfatases that can lead to impairment of the barrier function of the epithelial cell layer in IBD patients (Lucke et al., 2006) . Swidsinski et al. (2002) analysed gut microbiota mucosal biofilms in inflammatory and healthy volunteers using fluorescent in situ hybridization. As this method, also based on the 16S rRNA molecule, is targeting the rRNA, it gives insights into localization of active bacteria within the mucosa. Their work highlighted the strong prevalence of B. fragilis within the mucosa of IBD patients and mostly CD patients (Swidsinski et al., 2005) . Our results are consistent with their observation as the AIR of B. fragilis was the highest in CD patients (compared to healthy and UC individuals). The B. fragilis genome has been fully sequenced, analysed and led to the description of the phase inversion phenomenon in this species, with antigenic variation. The composition of the ten different polysaccharide biosynthesis gene clusters identified (seven with associated invertible promoters) suggested a mechanism of synthesis similar to the O-antigen capsules of Escherichia coli (Mazmanian et al., 2005) . Mazmanian et al. (2005) highlighted that B. fragilis expressing a specific surface polysaccharide (PSA presenting a zwitterionic structure) was sufficient to correct immunological defects observed in the absence of a commensal microbiota in axenic mice models. In the colonization phase, the B. fragilis PSA was able to mediate establishment of a proper T helper 1/T helper 2 cell balance through specific production of Th1 cytokines. More recently, the same group showed that B. fragilis protected its host from inflammatory disease caused by Helicobacter hepaticus in an experimental model of colitis and that this anti-inflammatory effect was mediated by the PSA molecule (Mazmanian et al., 2008) . However, the LPS of B. fragilis has been shown to trigger inflammatory events via the Tolllike receptor 2 and is likely to be involved in systemic inflammatory response syndrome caused by gut bacteria (Erridge et al., 2004) . However, this might not be paradoxical. Hence, Netea et al. (2004) observed that in patients with CD bearing the 3020insC mutation on NOD2, stimulation with B. fragilis led to a significantly lower interleukin 10/tumour necrosis factor alpha ratio than when wild-type NOD2 or healthy volunteers' cells were stimulated.
Our results showed a clear discrepancy between intestinal diversity or richness measured as the presence of 16S rRNA gene signatures of bacteria and their transcriptional or metabolic status (rRNA). Transcriptional activity is also a prerequisite for intestinal colonization of bacteria and can help in differentiating active bacteria from bacteria that were merely present (Lorenz & Wackernagel, 1987; Josephson et al., 1993; Wagner, 1994) . It was noteworthy that the most active bacteria associated with the human gut mucosa were also the less abundant. Indeed, the highest AIRs were observed for bacteria representing less than 1 % of total microbiota in each of the clinical groups. This phenomenon has also been observed at the mRNA level in another complex ecosystem (ocean surface water) using high throughput sequencing. While comparing bacterial cDNA to bacterial DNA, Frias-Lopez et al. (2008) observed that protein clusters with the highest cluster-based expression ratios also tended to fall into the low abundance category.
The role of the metabolic activity of specific bacteria or bacterial populations towards the pathogenesis of IBD remains unclear. A potential function is the production of health-promoting metabolites or precursors, as recently shown for Roseburia sp. (Devillard et al., 2007) . Differential activity of intestinal bacteria could also be the consequence of a complex self-regulation network via quorum-sensing mechanisms, which will arise as an important field of research in the future (Dunny et al., 2008) .
Our study shows that investigation of the transcriptional activity of intestinal bacteria can provide important additional information for the understanding of the complex composition of the intestinal microbiota. Data on the functional status of intestinal bacteria will increase the degree of complexity of the intestinal network that has been determined so far and will help in the understanding of regulatory processes.
